Become a worldwide leader in DNA based therapies
for companion and food animals utilizing proprietary plasmid based
DNA delivery and expression technology thereby optimizing an animal's
natural biological and immunological potential.
Strategic Intent
| |
 |
Launch the
company's first commercial product by the end of 2008.
|
| |
|
Create a financially independent
animal health company that delivers long term value to shareholders.
|
| |
|
Seek and establish strategic
alliances in global market segments to leverage and commercialize
proprietary GHRH technology in major companion and food animals.
|
| |
|
Develop a broad range
of DNA based products for major companion and food animal
species.
|
| |
|
Bring products to market
that meet significant unmet needs in improving animal health
and economics. |
